StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
JGCHEM.NS$426.60-1.96%
Fair $426.60+0.0%

JGCHEM.NS

JGCHEM.NS

Basic Materials / Other Industrial Metals & MiningNSE

$426.60

-8.55 (-1.96%)

Fairly Valued+0.0%Fair Value $426.60Fund rank 27/100 · Data gapFallback financials|
SA 59/C
F-Score: 3/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 19%

FCF escenarios

weak_data · normalized FCF $45.5M · quality 47.0/100

Data gap 27/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 19/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

59/100

C

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists.
Thesis & Journal · JGCHEM.NSLocal privado en este navegador · JGCHEM.NS
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$16.7B

P/E

25.4x

↑

EV/EBITDA

17.0x

↑

ROE

12.5%

↑

Gross Margin

17.2%

↓

Debt/Equity

0.01

↓
52-Week Range$427
$298$558

TradingView lightweight chart

JGCHEM.NS price, volumen y niveles de valoración

Último $426.60Periodo +130.8%
Fair value: $426.60

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

+7.4%

FCF CAGR

-40.2%

FCF margin

0.5%

FCF / Net income

0.07x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $9.73B · net income $658.8M · FCF $45.5M

2023-FY → 2026-FY

Gross margin

17.2%-1.3% pts

Operating margin

7.9%-1.4% pts

Net margin

6.8%-0.2% pts

FCF margin

0.5%-2.2% pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$9.73B$9.73B$8.48B$6.68B$7.85B
Net Income$658.8M$658.8M$640.1M$308.6M$549.4M
EBITDA$978.6M$978.6M$961.3M$509.4M$846.8M
EPS——16.349.6014.02
Gross Margin17.2%17.2%19.9%16.6%18.4%
Operating Margin7.9%7.9%9.5%6.2%9.3%
Net Margin6.8%6.8%7.5%4.6%7.0%
Balance Sheet
Debt/Equity0.010.010.000.030.34
Current Ratio18.6418.64———
Cash Flow
Free Cash Flow$45.5M$45.5M$-158.9M$665.1M$212.8M
Returns
ROE12.5%12.5%13.8%7.7%26.5%
Valuation
P/E25.3925.3919.7624.21—
EV/EBITDA16.9816.9812.8414.02—
P/B3.163.162.721.88—
Growth & Yield
Revenue Growth14.7%14.7%27.0%-14.9%—
EPS Growth——70.2%-31.5%—
Dividend Yield0.2%0.2%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +15.2%

Total return

+15.2%

Start / end P/E

n/dx → n/dx

EPS bridge

16.34 → n/d

Residual

+15.0%

EPS growthn/d
Multiple reratingn/d
Dividend+0.2%
Residual / FX / buybacks / cross-term+15.0%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.